We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+18.48%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$5.63B
AUM Growth
+$1.07B
(+23%)
Cap. Flow
+$732M
Cap. Flow
% of AUM
13%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
695
New
78
Increased
409
Reduced
177
Closed
27
Top Buys
| 1 |
Cognyte Software
CGNT
|
+$51.8M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$45.4M |
| 3 |
Mativ Holdings
MATV
|
+$37.9M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$37.4M |
| 5 |
Altria Group
MO
|
+$34.6M |
Top Sells
| 1 |
Tilray
TLRY
|
+$43M |
| 2 |
APHA
Aphria Inc. Common Shares
APHA
|
+$40M |
| 3 |
VRNT
Verint Systems
VRNT
|
+$35.2M |
| 4 |
GameStop
GME
|
+$18.6M |
| 5 |
ABST
Absolute Software Corp
ABST
|
+$18M |
Sector Composition
| 1 | Technology | 42.27% |
| 2 | Healthcare | 15.02% |
| 3 | Materials | 12.66% |
| 4 | Financials | 7.72% |
| 5 | Consumer Staples | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Kopin
KOPN
$684M
| $247K | ﹤0.01% |
+27,598
| New | +$209K |
|
602
OraSure Technologies
OSUR
$273M
| $245K | ﹤0.01% |
22,037
-12,769
| -37% | -$156K |
|
603
Aligos Therapeutics
ALGS
$35.6M
| $244K | ﹤0.01% |
467
-275
| -37% | -$183K |
|
604
Belden
BDC
$3.94B
| $238K | ﹤0.01% |
+5,556
| New | +$253K |
|
|
MAXN
605
DELISTED
Maxeon Solar Technologies
MAXN
| $237K | ﹤0.01% |
79
+10
| +14% | +$38.1K |
|
606
Marten Transport
MRTN
$1.45B
| $235K | ﹤0.01% |
13,735
-6,498
| -32% | -$110K |
|
|
CMRX
607
DELISTED
Chimerix, Inc.
CMRX
| $226K | ﹤0.01% |
26,290
-4,175
| -14% | -$38.3K |
|
608
Constellation Brands
STZ
$23.2B
| $216K | ﹤0.01% |
925
-1,615
| -64% | -$364K |
|
|
JOYY
609
JOYY Inc
JOYY
$3.49B
| $216K | ﹤0.01% |
2,254
-2,649
| -54% | -$286K |
|
|
HUYA
610
Huya Inc
HUYA
$551M
| $212K | ﹤0.01% |
10,943
-10,547
| -49% | -$265K |
|
611
Strategic Education
STRA
$1.76B
| $209K | ﹤0.01% |
2,301
+308
| +15% | +$27.6K |
|
|
VXRT
612
DELISTED
Vaxart
VXRT
| $209K | ﹤0.01% |
36,090
-17,155
| -32% | -$132K |
|
613
STAG Industrial
STAG
$8.04B
| $204K | ﹤0.01% |
+6,023
| New | +$192K |
|
614
Super Micro Computer
SMCI
$16B
| $200K | ﹤0.01% |
52,630
-1,810
| -3% | -$6.16K |
|
615
CEL-SCI Corp
CVM
$20.1M
| $193K | ﹤0.01% |
414
-214
| -34% | -$117K |
|
|
FIRY
616
Firy Inc
FIRY
$133M
| $188K | ﹤0.01% |
+518
| New | +$298K |
|
|
AAN
617
DELISTED
The Aaron's Company Inc
AAN
| $178K | ﹤0.01% |
7,050
+945
| +15% | +$20.7K |
|
618
BorgWarner
BWA
$12.9B
| $175K | ﹤0.01% |
+4,263
| New | +$166K |
|
619
Fate Therapeutics
FATE
$318M
| $168K | ﹤0.01% |
2,263
-13,323
| -85% | -$1.28M |
|
620
Domo
DOMO
$150M
| $166K | ﹤0.01% |
3,118
+41
| +1% | +$2.66K |
|
621
Unisys
UIS
$277M
| $166K | ﹤0.01% |
6,562
-65
| -1% | -$1.61K |
|
622
Century Aluminum
CENX
$4.22B
| $164K | ﹤0.01% |
9,504
-3,482
| -27% | -$49.6K |
|
|
SYRS
623
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $161K | ﹤0.01% |
2,227
-718
| -24% | -$74.6K |
|
624
SIGA Technologies
SIGA
$255M
| $155K | ﹤0.01% |
23,709
-13,938
| -37% | -$94.5K |
|
|
PRA
625
DELISTED
ProAssurance
PRA
| $154K | ﹤0.01% |
5,765
-2,105
| -27% | -$48.7K |
|
Similar funds
AIA
PFM
DKP
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q1 2021 Portfolio in Review
As of Q1 2021, ETF Managers Group held 695 positions worth $5.63B, up 23% from $4.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ETF Managers Group deployed $732M of net new capital in Q1 2021, opening 78 new positions and adding to 409 existing holdings. Its largest new stake was Cognyte Software: 1,743,286 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 52% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Tilray, an estimated $43M trimmed.
- ETF Managers Group's largest Q1 2021 buy was Cognyte Software: 1,743,286 shares worth $47.8M.
- ETF Managers Group added most to GW Pharmaceuticals Plc American Depositary Shares in Q1 2021, an estimated $45.4M increase.
- ETF Managers Group's biggest Q1 2021 reduction was Tilray, cutting an estimated $43M.
- ETF Managers Group fully exited Tvardi Therapeutics in Q1 2021, selling an estimated $6.57M.
- ETF Managers Group's ten largest holdings make up 20% of its $5.63B portfolio in Q1 2021.
- ETF Managers Group opened 78 new positions and closed 27 in Q1 2021.
- ETF Managers Group's portfolio value rose 23% quarter-over-quarter to $5.63B.
Based on ETF Managers Group's 13F filing for Q1 2021, filed 17 May 2021.